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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Since little has been reported in previous studies, we aimed to find the
clinical and electrophysiologic characteristics associated with childhood Guillain-Barre´
Syndrome (GBS) in Northeast China.
Methods: The clinical and electrophysiologic data were collected and reviewed retrospectively
in 33 children and 105 adults with GBS during the period between 2006 and 2010 from the First
Hospital of Jilin University.
Results: Most of the children with GBS were older than 8 years of age and symptoms were
severe at GBS onset. Simultaneous involvement of four limbs was the most common clinical
feature, and cranial nerve involvement was common; however, previous infection, sensory
nerve involvement and elevated proteins in cerebrospinal fluid occurred much less in the chil-
dren with GBS than those in adult patients. Recruited children were classified as having acute
inflammatory demyelinating polyneuropathy (AIDP; 41%), acute motor axonal neuropathy
(AMAN; 38%), and were unclassified (21%). Electrophysiologic features and prognosis in these
children were not different from those in adults. For children with AMAN, the efficacy of intra-
venous immunoglobulin (IVIg) was not different from that in adults; however, IVIg was not
significantly effective for AIDP in these children.
Conclusion: Childhood GBS in Northeast China exhibits characteristics of clinical and electro-
physiologic alternations; early diagnosis and appropriate treatments should be provided
accordingly.
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Guillain-Barre´ Syndrome (GBS) is the most common cause of
acute and severe generalized peripheral neuropathic
weakness.1 Studies have found that one-third of childhood
cases occur before the age of 3 years, and 50%e70% of the
cases have an antecedent infection 2e4 weeks prior to GBS
onset.2,3 Weakness usually starts in the lower extremities,
and sensory abnormalities and cranial nerve involvements
are common in childhood GBS. Some reports have empha-
sized that in China, acute motor axonal neuropathy (AMAN)
primarily affects children, and it is controversial as to
whether AMAN is associated with a poor prognosis. Addi-
tionally, some studies indicate that prognosis is better in
children than that in adults.4,5 However, little has been
reported regarding the clinical and electrophysiological
features present in children with GBS in Northeast China.
Here we aimed to determine whether there were identifi-
able clinical and electrophysiologic characteristics of
childhood GBS in order to make early diagnosis and appro-
priate treatments.Materials and methods
Patients
A retrospective study was performed for this study. Thirty-
three children (age younger than 15 years) and 105 adults
with GBS who were admitted to the First Hospital of Jilin
University between 2006 and 2010 were recruited. All
patients came from Jilin province, Northeast China and
fulfilled the clinical criteria for GBS.6 Patient criteria were
evaluated using the functional grading scale produced by
Hughes et al.7 The patients were classified as severely
affected (inability to walk when unaided, GBS disability
scale 3) or mildly affected. Lumbar puncture (normal cell
count value: 5/mL, normal protein: 45 mg/dL) was per-
formed in children between 10 and 16 days (mean 12.7
days) after GBS onset. In adults the lumbar puncture was
performed between 10 and 17 days (mean 12.5 days) after
GBS onset. Intravenous immunoglobulin (IVIg) was admin-
istered when GBS was diagnosed and efficacy of IVIg was
measured approximately 2 weeks after IVIg treatment. The
efficacy was considered as improved if there was an
increase in one or more points in Hughes score.
Electrophysiology
Nerve conduction studies (NCSs) were performed using
conventional procedures. Motor NCS was performed on the
median, ulnar, posterior tibial, and deep peroneal nerves.
Stimulus sites for the median and the ulnar nerves were
defined at the wrist and elbow and electrophysiologic
recordings were performed in the abductor pollicis brevis
and the abductor digit minimi. The stimulus site for the
tibial nerve was at the ankle and popliteal fossa and the
recording was conducted in the fiexor hallucis brevis. For
the deep peroneal nerve at the ankle and fibular head, the
recording was in the extensor digitorum brevis muscle.
Sensory NCS included stimulation of the median nerve,ulnar nerve, superficial peroneal nerve, and sural nerve. F
waves of the median and ulnar nerves were measured after
compound muscle action potentials (CMAPs) were obtained
in the motor NCS. The H reflex of the posterior tibial nerve
was recorded from the gastrocnemius muscle. CMAP
amplitude, distal motor latency, motor nerve conductive
velocities (MCVs), conduction block, sensory nerve
conductive velocities (SCVs), sensory nerve amplitude,
average F response latencies, F wave incidence, and H
reflex amplitude and latency were measured. Needle
electrode examination (NEE) of the extensor digitorum
communis and tibialis anterior muscles was performed.
Values were defined as abnormal if they were outside of the
age corrected normal range. Patients were classified as
having AMAN or acute inflammatory demyelinating poly-
neuropathy (AIDP) on the basis of the electrodiagnostic
criteria reported by Hughes and colleagues.8 A diagnosis of
AIDP was made if at least one of the following parameters
were present in each of at least two nerves, or at least two
of the following parameters in one nerve if all others were
unexcitable and the CMAP amplitude after distal stimula-
tion (dCMAP) >10% lower limit of normal (LLN). These
parameters included MCV <90% LLN (85% if dCMAP <50%
LLN), distal motor latency >110% upper limit of normal
(ULN; >120% if dCMAP <100% LLN), CMAP amplitude after
proximal stimulation (pCMAP)/dCMAP ratio <0.5, and
dCMAP >20% LLN; F wave latency >120% ULN). AMAN was
diagnosed as none of the features of AIDP except one
demyelinating feature allowed in one nerve if dCMAP <10%
LLN, and sensory action potential amplitudes are normal.
The study protocol was approved by the Human Ethics
Committee of Jilin province, P. R. China, and informed
consent was obtained from all patients.
Statistical analysis
Differences in proportions were tested with the Chi-square
test. A p value of <0.05 was considered significant.
Results
Clinical features of childhood GBS
The clinical data were summarized in Table 1. Twenty-
seven patients of childhood GBS were older than 8 years
of age. Simultaneous involvement of four limbs was one of
the most common clinical features. Cranial nerve involve-
ment (mainly facial nerve palsy and glossopharyngeal and
vagal nerve involvements with dysphagia, choking cough,
and dyspnea) was also common. Children with GBS had
fewer previous infections (mainly gastroenteritis and
respiratory infection), sensory abnormalities (mainly
symmetrical numbness of the distal limbs and tingling), or
elevated proteins in the cerebrospinal fluid when compared
with adult patients. Clinical presentations in children with
GBS were more severe than adult patients, six (18%) and 33
(31%) were mild patients in children and adults, respec-
tively, of which two children and two adults deteriorated
within 7 days after admitted to hospital. However, we
found that treatment of IVIg in children was not as effective
as in adults.
Table 1 Clinical features of all GBS patients.
Number of
children (%)
Number of
adults (%)
p
value
Males/females 21/12 65/40 NS
Mean age (y) 9.7 39.0
Previous infection 12 (36%) 69 (66%) <0.05
Gastroenteritis 4/12 (33%) 47/69 (68%) <0.05
Muscle weakness 33 (100%) 101 (96%) NS
Lower limbs 13 (39%) 27 (27%) NS
Upper limbs 6 (18%) 20 (20%) NS
Four limbs 14 (43%) 54 (53%) NS
Reduced or absent
deep tendon reflexes
33 (100%) 101 (96%) NS
Sensory disturbance 6 (18%) 46 (44%) <0.05
Cranial nerve
involvement
11 (33%) 24 (23%) NS
Severity at admission
Mild 6 (18%) 33 (31%) NS
Severe 27 (82%) 72 (69%) NS
Elevated CSF
protein level
15/22 (68%) 71/78 (91%) <0.05
Efficacy of IVIg 22 (67%) 91 (89%) <0.05
CSF Z cerebrospinal fluid; GBS Z Guillain-Barre´ syndrome;
IVIg Z intravenous immunoglobulin; NS Z not significant.
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NCSs were performed in 73 cases, including 19 children and
54 adults within 14 days of GBS onset, and NCS wasTable 2 Electrophysiologic features of patients with GBS.
Numbe
Motor NCS
Abnormal total 27 (
Low CMAP amplitude 27 (
Slow MCV 18 (
Prolonged distal latency 14 (
Conduction block 3 (
Sensory NCS
Abnormal total 8 (
Low SNAP amplitude 8 (
Slow SCV 7 (
F waves
Abnormal total 18/28 (
Absent/low incidence 18/28 (
Prolonged latency 11/28 (
H reflex
Abnormal total 14/23 (
Absent/low amplitude 11/23 (
Prolonged latency 9/23 (
NEE
Fibrillation/þ sharp waves 6/21 (
Absent/reduced number of motor unit potential 6/21 (
Absent/reduced recruitment 21/21 (
CMAP Z compound muscle action potential; GBS Z Guillain-Barre´ sy
conduction studies; NEE Z needle electrode examination; NS Z
SNAP Z sensory nerve action potential.performed in 65 cases (14 children, 51 adults) 14 days after
GBS onset. The average time was 12.6 and 13.5 days after
GBS onset in child and adult patients, respectively.
Neurophysiologic data is summarized in Table 2. No signif-
icant difference in NCS (p > 0.05) was found between
children and adult patients. Abnormal motor NCS (mainly
low CMAP amplitude), F waves, and H reflex were the most
common electrophysiologic symptoms observed in these
two groups.AMAN and AIDP
Twenty-nine of 33 children patients showed abnormal
electrophysiologic features based on electrophysiologic
criteria; these patients were classified as having AIDP
(n Z 12, 41%) or AMAN (n Z 11, 38%), or unclassified
(nZ 6, 21%). Ninety-six of 105 adult patients had abnormal
electrophysiologic features, which were classified as having
AIDP (n Z 54, 56%), AMAN (n Z 22, 23%), or unclassified
(n Z 20, 21%, including three adults with AMAN). Twenty-
seven patients with AMAN (nine children and 18 adults)
and 54 patients with AIDP (11 children and 43 adults) were
followed up for approximately 6 months. The severity of
AMAN and AIDP patients is summarized in Table 3.
A summary of nerve involvements patients with AMAN and
AIDP is presented in Table 4. In children, 91% of patients
with AMAN and 75% of patients with AIDP were severe at
onset of GBS. In adult cases, 91% of patients with AMAN and
74% of patients with AIDP had severe symptoms at the onset
of GBS, and no significant difference was found between
children and adult patients. Moreover, no significantr of children (%) Number of adults (%)
82%) 85 (81%) NS
82%) 84 (80%) NS
55%) 54 (52%) NS
42%) 49 (47%) NS
9%) 14 (13%) NS
24%) 32 (31%) NS
24%) 28 (27%) NS
21%) 19 (18%) NS
64%) 61/99 (62%) NS
64%) 55/99 (56%) NS
39%) 39/99 (39%) NS
61%) 36/63 (57%) NS
48%) 33/63 (52%) NS
39%) 29/63 (41%) NS
29%) 48/83 (58%) p < 0.05
29%) 24/83 (29%) NS
100%) 83/83 (100%) NS
ndrome; MCV Z motor nerve conductive velocities; NCS Z nerve
not significant; SCV Z sensory nerve conductive velocities;
Figure 1 Improvement of Hughes grade after IVIg treatment.
Childhood GBS cases that had no recovery or rapid recovery
(patients who improved two or more Hughes grades) was higher
in AMAN (36%, 36%, respectively) than AIDP (25%, 0%,
respectively).
Table 3 Percentage of severe patients with AMAN or AIDP
at different time points.
Hospital
admission
1 month
later
6 months
later
Number of children (%)
AIDP 9/12 (75%) 5/12 (41%) 2/11 (18%)
AMAN 10/11 (91%) 6/11 (54%) 2/9 (22%)
Number of adults (%)
AIDP 40/54 (74%) 16/54 (29%) 4/43 (9%)
AMAN 20/22 (91%) 15/22 (68%) 3/18 (16%)
AIDP Z acute inflammatory demyelinating polyneuropathy;
AMAN Z acute motor axonal neuropathy.
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between childhood and adult cases (p > 0.05) according to
the Hughes score after 6 months of GBS onset.
All patients with AMAN or AIDP were treated with IVIg.
The results of the efficacy of IVIg in children are summa-
rized in Fig. 1. The number of children that did not recover
and with rapid recovery (patients who improved two or
more Hughes grades) in AMAN (36% and 36%, respectively)
were greater than that in children with AIDP (25% and 0%,
respectively). The efficacy of IVIg among childhood and
adult cases are summarized in Fig. 2. For children with
AMAN, the efficacy of IVIg was not different from adults.
However, IVIg was not very effective for children with AIDP,
and 25% of cases did not recover and none had rapid
recovery.
Discussion
GBS is an autoimmune acute peripheral neuropathy.
Previous reports from other countries have shown that
50%e70% of GBS had an antecedent infection, and most of
those were upper respiratory tract infections or gastroen-
teritis that occurred within 6 weeks of symptom onset.Table 4 Percentage of involved nerves in patients with
AMAN and AIDP.
Number of
children (%)
Number of
adults (%)
AIDP AMAN AIDP AMAN
Motor nerves
Median nerve 82 100 72 77
Ulnar nerve 100 100 71 91
Posterior tibial nerve 100 100 84 78
Deep peroneal nerve 92 100 81 82
Sensory nerves
Median nerve 56 d 56 d
Ulnar nerve 50 d 57 d
Superficial peroneal
nerve
33 d 50 d
Sural nerve 10 d 24 d
AIDP Z acute inflammatory demyelinating polyneuropathy;
AMAN Z acute motor axonal neuropathy.Approximately one-third of childhood cases occur before
the age of 3 years and occasionally neonatal cases have
been described previously.2,3 Clinically, weakness starts in
the lower extremities and progressively ascends to the
upper extremities. Sensory abnormalities and cranial nerve
involvement are often observed in childhood GBS (approx-
imately 45% children with GBS exhibited facial nerve
palsy).9 A study from South China showed that most chil-
dren with GBS were younger than 6 years of age and the
mean age was 5.1 years, and no infective etiology could be
identified.10 In this study, most children with GBS were
older than 8 years of age (n Z 27). Childhood GBS in
Northeast China had a lower incidence (36%) of antecedentFigure 2 Improvement of Hughes grade after IVIg treatment.
In childhood and adult GBS, the efficacy of IVIg was not
different from adults in AMAN patients; however, IVIg was not
significantly effective for children with AIDP, of which 25% of
the cases had no recovery and none had rapid recovery.
638 Y.-Q. Ye et al.infection (mainly gastroenteritis and respiratory infection)
when compared with that in other countries and adult
patients (66%) in Northeast China; however, the incidence
was higher than that in South China. The dominant clinical
features of childhood GBS were muscle weakness and
reduced or absent deep tendon reflexes (100%), and 43% of
patients had these symptoms in all four limbs simulta-
neously. Only 18% of patients had sensory disturbances,
while cranial nerve involvement (mainly facial nerve palsy
and glossopharyngeal and vagal nerve involvement)
occurred more in children than in adult patients. Childhood
GBS was more severe at the onset (82%). Moreover, IVIg was
not significantly effective (67%) when compared with adult
patients (89%). It is worthwhile to mention that small fiber
involvements have recently been reported to exist in
a significant proportion of patients with GBS.11,12 The
limitation of this study was that the small fiber neuropathy
was not studied. Symptoms of small fiber neuropathy and
cutaneous innervation will be an important focus of our
future research.
NCS is vital for the diagnosis of GBS.13 Systemic NCS is
reported less in childhood GBS. Previous studies have shown
an increase in distal latency and a decrease in nerve
conduction in the children with GBS, which primarily
reflects peripheral nerve demyelination. Abnormal F waves
and H reflex were observed as well in this study.14 In
addition, prolonged latency has commonly been reported in
childhood GBS in South China.10 In this study, although no
significant difference was found between children and
adult patients, when compared with that in South China
and other countries, abnormal motor NCS (mainly low CMAP
amplitude), F waves, and H reflex were commonly seen and
only 24% childhood cases had abnormal sensory NCS, which
suggested that the motor nerves were more involved in
childhood GBS in Northeast China. Motor nerve involvement
was more common in children than that in adults with AMAN
or AIDP, while in children with AIDP, sensory nerve
involvement in the lower limbs was less common than that
in adults (Table 4).
Previous reports have found that AIDP is themost frequent
subtype of GBS in North America and Europe,4 while in China
AMAN mainly affects children. It is controversial as to
whether AMAN is associated with a poor prognosis, some
studies give a conclusion that prognosis is better in children
than in adults, while other reports have shown that no
difference in prognosis is found between children and
adults.4,5,15e18 In this study, AIDP (41%)was themain subtype
of childhoodGBS; however, theproportionof AMAN (38%)was
higher in childhood than in adult patients (23%). For AMAN
and AIDP patients, the severity at GBS onset and the prog-
nosis (6 months after GBS onset) were not significantly
different between children and adults. After IVIg treatment,
the number of children with AMAN that did not recover and
those that had a rapid recovery was greater than children
with AIDP. Perhaps severe immune responses leading to
severe axonal loss attenuated the beneficial response of
AMAN patients to IVIg. Cases with rapid recovery may have
had mild axonal loss at motor nerve terminals, which may
also explain the recovery of children with AMAN when
compared with adults with AMAN after IVIg treatments.
However, in patients with AIDP, adults had a greater benefit
from IVIg treatment than children; this result may suggestthat not only severe demyelination but also axonal loss
occurs in children with AIDP in Northeast China.
In conclusion, in Northeast China, most children with
GBS were older than 8 years of age and had severe symp-
toms at GBS onset. Simultaneous involvement of four limbs
was the most common clinical feature, and cranial nerve
involvement was common as well. Furthermore, there were
fewer previous infections and sensory abnormalities in
children when compared with adult patients. AIDP was the
main subtype of childhood GBS, and electrophysiologic
features and prognosis were not different from adults. For
children with AMAN, the efficacy of IVIg treatment was not
different from adults. However, IVIg treatment in children
with AIDP was not as effective when compared with results
in adult patients.
Acknowledgments
The authors sincerely thank our departmental colleagues
for supplying clinical and electrophysiologic data and for
their support of this work.
References
1. Weinberg DH. AAEM case report 4: Guillain-Barre syndrome.
American Association of Electrodiagnostic Medicine. Muscle
Nerve 1999;22:271e81.
2. Delanoe C, Sebire G, Landrieu P, Huault G, Metral S. Acute
inflammatory demyelinating polyradiculopathy in children: clin-
ical and electrodiagnostic studies. Ann Neurol 1998;44:350e6.
3. Epstein MA, Sladky JT. The role of plasmapheresis in childhood
Guillain-Barre syndrome. Ann Neurol 1990;28:65e9.
4. Nagasawa K, Kuwabara S, Misawa S, Fujii K, Tanabe Y, Yuki N,
et al. Electrophysiological subtypes and prognosis of childhood
Guillain-Barre syndrome in Japan. Muscle Nerve 2006;33:
766e70.
5. Incecik F, Ozlem Herguner M, Altunbasak S. Guillain-Barre
syndrome in children. Neurol Sci 2011;32:381e5.
6. Asbury AK, Cornblath DR. Assessment of current diagnostic
criteria for Guillain-Barre syndrome. Ann Neurol 1990;(27
Suppl):S21e4.
7. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled
trial prednisolone in acute polyneuropathy. Lancet 1978;2:
750e3.
8. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet
2005;366:1653e66.
9. Lee JH, Sung IY, Rew IS. Clinical presentation and prognosis of
childhood Guillain-Barre syndrome. J Paediatr Child Health
2008;44:449e54.
10. Ma YM, Liu TK, Wong V. Guillain-Barre syndrome in southern
Chinese children: 32 year experience in Hong Kong. Pediatr Int
2010;52:13e9.
11. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST.
Cutaneous innervation inGuillain-Barre´ syndrome: pathology
and clinical correlations. Brain 2003;126:386e97.
12. Ruts L, van Doorn PA, Lombardi R, Haasdijk ED, Penza P,
Tulen JH, et al. Unmyelinated and myelinated skin nerve
damage in Guillain-Barre´ syndrome: correlation with pain and
recovery. Pain 2012;153:399e409.
13. Korinthenberg R, Schessl J, Kirschner J. Clinical presentation
and course of childhood Guillain-Barre syndrome: a prospec-
tive multicentre study. Neuropediatrics 2007;38:10e7.
14. Ryan MM. Guillain-Barre syndrome in childhood. J Paediatr
Child Health 2005;41:237e41.
Childhood GBS in China 63915. Lu JL, Sheikh KA, Wu HS, Zhang J, Jiang ZF, Cornblath DR, et al.
Physiologic-pathologic correlation in Guillain-Barre syndrome
in children. Neurology 2000;54:33e9.
16. Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T,
Koga M, et al. Patterns and serial changes in electrodiagnostic
abnormalities of axonal Guillain-Barre syndrome. Neurology
2005;64:856e60.17. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
Axonal Guillain-Barre syndrome: relation to anti-ganglioside
antibodies and Campylobacter jejuni infection in Japan. Ann
Neurol 2000;48:624e31.
18. Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R,
Dhawan B. Outcome in childhood Guillain-Barre syndrome.
Indian J Pediatr 2009;76:795e9.
